Alli obesity drug launched OTC in Europe
GlaxoSmithKline (GSK) has launched its weight loss drug, alli, in Europe as an over-the-counter (OTC) offering after receiving European approval to do so in January, in a move that will have an undoubted impact on the weight management food supplements...